tetrodotoxin has been researched along with Myalgia* in 1 studies
1 other study(ies) available for tetrodotoxin and Myalgia
Article | Year |
---|---|
Antihyperalgesic effect of tetrodotoxin in rat models of persistent muscle pain.
Persistent muscle pain is a common and disabling symptom for which available treatments have limited efficacy. Since tetrodotoxin (TTX) displays a marked antinociceptive effect in models of persistent cutaneous pain, we tested its local antinociceptive effect in rat models of muscle pain induced by inflammation, ergonomic injury and chemotherapy-induced neuropathy. While local injection of TTX (0.03-1 μg) into the gastrocnemius muscle did not affect the mechanical nociceptive threshold in naïve rats, exposure to the inflammogen carrageenan produced a marked muscle mechanical hyperalgesia, which was dose-dependently inhibited by TTX. This antihyperalgesic effect was still significant at 24h. TTX also displayed a robust antinociceptive effect on eccentric exercise-induced mechanical hyperalgesia in the gastrocnemius muscle, a model of ergonomic pain. Finally, TTX produced a small but significant inhibition of neuropathic muscle pain induced by systemic administration of the cancer chemotherapeutic agent oxaliplatin. These results indicate that TTX-sensitive sodium currents in nociceptors play a central role in diverse states of skeletal muscle nociceptive sensitization, supporting the suggestion that therapeutic interventions based on TTX may prove useful in the treatment of muscle pain. Topics: Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Male; Motor Activity; Muscle, Skeletal; Myalgia; Nociceptive Pain; Organoplatinum Compounds; Oxaliplatin; Pain Threshold; Rats, Sprague-Dawley; Tetrodotoxin; Touch | 2015 |